Option Care Health Selected as a Limited Distribution Provider of VILTEPSO™ (viltolarsen) Injection for Patients with Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy BANNOCKBURN, Ill., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion...

Option Care Health Selected as Preferred Pharmacy Partner To Prepare and Distribute Breakthrough Cancer Therapy BANNOCKBURN, Ill., May 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate...

Option Care Health Collaborating with Leading Health Systems to Accelerate Patient Discharges During the COVID-19 Pandemic BANNOCKBURN, Ill., April 14, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion...

Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment BANNOCKBURN, Ill., Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc., the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been...